[Frequency of terminally differentiated fibroblasts in the synovial membrane of rheumatoid arthritis patients].
The metabolic activation of synovial fibroblasts (SF) and their expression of matrix degrading enzymes and inflammatory cytokines contributes to the pathology of rheumatoid arthritis (RA). It is remarkable that SF of RA patients do not proliferate at higher rates when compared to SF of other patients, but they are resistant to apotposis inducing signals. The chronic inflammation in RA causes fibrosis of the synovial tissue and fibrosis has been associated with terminal differentiation. Therefore we investigated if there are increased numbers of terminally differentiated fibroblasts in the RA synovium and if there is a correlation between terminal differentiation of SF and increased levels of expression of interleukins and matrix metalloproteinases. We analyzed specimen of four RA patients, two patients with osteoarthritis (OA) and two healthy donors suffering from joint injuries. By use of RT-PCR techniques we examined mRNA expression of two genes in SF which are associated with terminal differentiation, p16INK4a and p21-cip. In addition, we labelled differentiated fibroblasts using the SA-beta-galaktosidase assay and investigated differences in protein expression patterns of factor PIVa and the tropomyosin 1 and 2 molecules. We report that the number of terminally differentiated fibrolasts are not increased in the synovial membrane of RA patients. On the contrary we show that the synovia of the much younger patients has higher levels of terminally differentiated fibroblasts. Consequently, the fibrosis of synovial tissues in RA patients at later stages of disorder is not associated with proliferation and differentiation of the fibroblasts but rather a consequence of chronic inflammation.
Schmid
M
M
Zellbiologisches Forschungslabor, Orthopädische Universitätsklinik, Pulvermühlstr. 5, 72070 Tübingen, Germany.
Rodemann
H-P
HP
Aicher
W K
WK
D000328:Adult; D000368:Aged; D017209:Apoptosis / Q000502:physiology; D001172:Arthritis, Rheumatoid / Q000473:pathology*; D001706:Biopsy; D002454:Cell Differentiation / Q000502:physiology*; D049109:Cell Proliferation; D002478:Cells, Cultured; D005260:Female; D005347:Fibroblasts / Q000473:pathology*; D005355:Fibrosis; D006801:Humans; D019410:Interleukin-16 / Q000378:metabolism; D008297:Male; D019278:Matrix Metalloproteinase 3 / Q000378:metabolism; D008875:Middle Aged; D009000:Monocytes / Q000473:pathology; D010003:Osteoarthritis / Q000473:pathology; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013583:Synovial Membrane / Q000473:pathology*; D014947:Wounds and Injuries / Q000473:pathology; D001616:beta-Galactosidase / Q000378:metabolism
D019410:Interleukin-16; D001616:beta-Galactosidase; D019278:Matrix Metalloproteinase 3